Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Nifty MidSmall Healthcare
Nifty MidSmall Healthcare Performance
Day's Range
Low
₹49,170.25
High
₹49,729.20
52 Week Range
Low
₹40,352.90
High
₹49,836.85
| Previous Close | ₹49,301.95 |
|---|---|
| Day's Range | ₹49,170.25 - ₹49,729.20 |
| Open | ₹49,394.25 |
| 52 Week Range | ₹40,352.90 - ₹49,836.85 |
| Volume | 6,55,46,643 |
Nifty MidSmall Healthcare Companies
| Company Name | LTP (₹) | Change (₹) | Sector |
|---|---|---|---|
| Lupin Ltd. | 2367.60 |  9.80 (0.42%) |
Healthcare |
| Abbott India Ltd. | 25595.00 | 25.00 (0.10%) |
Healthcare |
| Glaxosmithkline Pharmaceuticals Ltd. | 2366.60 |  -30.10 (-1.26%) |
Healthcare |
| Pfizer Ltd. | 4507.20 | 10.20 (0.23%) |
Healthcare |
| JB Chemicals & Pharmaceuticals Ltd. | 2233.00 | -4.00 (-0.18%) |
Healthcare |
| Ipca Laboratories Ltd. | 1621.20 | -3.80 (-0.23%) |
Healthcare |
| Neuland Laboratories Ltd. | 18072.00 | -30.00 (-0.17%) |
Healthcare |
| Aurobindo Pharma Ltd. | 1530.60 | -3.60 (-0.23%) |
Healthcare |
| Natco Pharma Ltd. | 893.60 | 0.70 (0.08%) |
Healthcare |
| Poly Medicure Ltd. | 1650.90 | 0.90 (0.05%) |
Healthcare |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 24021.65 | 26373.20 | 22182.55 |
| Nifty IT | 27566.7 | 40301.40 | 26634.50 |
| Nifty Next 50 | 72060.5 | 73141.05 | 59896.10 |
| NIFTY50 USD Index | 8790.5 | 10443.40 | 8132.40 |
| Nifty Bank | 58150.35 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 62135.25 | 62909.55 | 52032.85 |
| Nifty 500 | 23126.3 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 17690.3 | 17859.10 | 14804.55 |
| Nifty 100 | 25075.95 | 26975.15 | 22720.45 |
| Nifty FMCG | 49085.1 | 58485.05 | 45334.15 |
Latest News
Biocon informs about press release
Biocon has informed that it enclosed the press release titled ‘Biocon Reinforces Commitment to Diabetes Care in Malaysia as Partner Duopharma Biotech Secures Insulin Tenders’. The above information will also be available on the website of the Company at www.biocon.com.
Narayana Hrudayalaya submits analyst meet intimation
Poly Medicure submits intimation for schedule of investor meet
Ipca Laboratories informs about trading window closure
Aurobindo Pharma informs about press release
Aurobindo Pharma has informed that it enclosed a copy of the Press Release that is being issued by the Company in connection with receipt of approval by Aurobindo Pharma USA, Inc. (‘Aurobindo USA’), a wholly owned subsidiary of the Company from the U.S. Federal Trade Commission (FTC) to proceed with the acquisition of Lannett Company LLC (‘Lannett’).
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The previous close of NFTMIDSMLHEALTH index is ₹49201.0 as of 2026-06-24.
The total volume of NFTMIDSMLHEALTH index is 65527451.00 as of 2026-06-24.
The percentage change in value of NFTMIDSMLHEALTH index is -0.20% as of 2026-06-24.
The absolute increase in NFTMIDSMLHEALTH index value since the previous trading day is ₹-100.95 as of 2026-06-24.
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
